Kristie L. Kahl

Racial disparities in palliative and hospice care beliefs appear to influence early integration in to standard oncologic care for patients with advanced lung cancer.

An expert from Texas Oncology offers perspective on findings from the CCGA study – presented at the 2018 ASCO Annual Meeting – which may support the use of a blood test to detect lung cancer earlier.

In this week’s episode of CURE Talks Cancer, we spoke with lung cancer survivor Taylor Bell Duck about her cancer journey and celebrating survivorship 10 years later.

The Food and Drug Administration (FDA) approved Leukine (sargramostim) for the treatment of adult and pediatric patients who are exposed to myelosuppressive doses of radiation that results in a hematopoietic subsyndrome of acute radiation syndrome.

The Food and Drug Administration (FDA) approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to reduce the risk for febrile neutropenia in patients treated with chemotherapy in certain types of cancer.

The House of Representatives has passed a controversial right-to-try bill that would give critically ill patients quick access to experimental drugs.

Despite improved outcomes, the researchers also found that side effects with checkpoint inhibition often affected the dermatologic, gastrointestinal, pulmonary, renal, endocrine and hepatic systems in patients.

In this week’s episode of CURE Talks Cancer, we spoke with Matt Lashey, creator and CEO of the chemoWave app, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment.

Although still in early phases, an oncolytic virus, called DNX-2401, may be a groundbreaking therapy in pediatric patients with diffuse intrinsic pontine gliomas.

CURE spoke with a childhood development specialist and colorectal cancer survivor to offer firsthand advice and tips on how to discuss a cancer diagnosis with children of any age.

We spoke with an expert about navigating at-home genetic testing kits, which are growing in popularity.

During the fourth annual Virginia Vines event, the V Foundation helped raise funds for cancer research and provided education on recent advancements in the treatment landscape.

The Food and Drug Administration (FDA) granted approval to Darzalex (daratumumab) in combination with Velcade (bortezomib), melphalan and prednisone – also known as VMP – for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).

The chemoWave app, launched in July 2017, is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being.

Palliative care can be used at all cancer stages, and can drastically improve patients' quality of life.

With the number of treatment options consistently increasing, tumor testing is growing more important to personalize care for women with ovarian cancer.

An evening of storytelling among women afflicted by ovarian cancer – whether it be their own diagnosis or a loved one’s – helped to empower individuals to find their voice.

Sherry Pollex, founder of SherryStrong.com, offered women a variety of ways to lead a healthier lifestyle during treatment, and an array of hope to go through their journeys with joy and thanks.

Stephanie V. Blank, M.D., talks about the MAGENTA study, designed to ease the time-consuming process for which women undergo genetic testing.

During the 2018 National Ovarian Cancer Coalition, Angeles Alvarez Secord, M.D., MHSc highlighted the importance of genetic testing and its impact on treatment options for women with ovarian cancer.

The National Colorectal Cancer Roundtable has created a special toolkit to help physicians successfully determine and evaluate family history to detect colorectal cancer at an earlier age.

Hear from our four Ovarian Cancer Heroes about what inspires them in the fight against the disease.

Researchers evaluates microsatellite instability-high status, tumor mutation burden and high PD-L1 expression to determine which grade of tumors would benefit from immunotherapy treatment among women with endometrioid endometrial cancer.

Albeit growing popularity of at-home genetic testing, it is still necessary to seek professional medical opinions from genetic counselors to help discuss results.

Berubicin showed promise in the treatment of glioblastoma as a drug that was able to cross the blood-brain barrier.

If patients with colon cancer follow the previously-issued American Cancer Society guidelines on nutrition and physical activity, they can improve outcomes in to survivorship.

As part of the Prostate Cancer Foundation’s first annual campaign, Kristen Bell selected two winners because of their ‘candor and honesty’ to be honored.

While previous studies showed bright white light therapy could prevent cancer-related fatigue, researchers also found it improves poor sleep efficiency among a variety of tumor types.

Israeli study shows cannabis is safe and effective for the palliative treatment of patients with cancer.

Despite exciting developments of PARP inhibitors over the years, limited knowledge exists in the mechanism of PARP-7 and its potential effect in targeted therapy for patients with ovarian cancer.